Exane Derivatives’s State Street SPDR Bloomberg 1-3 Month T-Bill ETF BIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,520
Closed -$322K 807
2022
Q1
$322K Hold
3,520
0.09% 241
2021
Q4
$322K Hold
3,520
0.08% 255
2021
Q3
$322K Hold
3,520
0.08% 268
2021
Q2
$322K Buy
+3,520
New +$322K 0.07% 268

Other funds holding BIL

Exane Derivatives's BIL Position: Q2 2022 in Review

Exane Derivatives sold out of State Street SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) in Q2 2022, closing a stake of 3,520 shares — an estimated $322K sold.

Exane Derivatives first reported a position in BIL in Q2 2021 and held it in 4 quarters. The position peaked at $322K in Q2 2021. 506 funds tracked by Wall St. Rank hold BIL as of Q2 2022.

  • Exane Derivatives reported no remaining State Street SPDR Bloomberg 1-3 Month T-Bill ETF position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 3,520 State Street SPDR Bloomberg 1-3 Month T-Bill ETF shares in Q2 2022, an estimated $322K.
  • Exane Derivatives first reported a position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2021 and held it in 4 quarters.
  • Exane Derivatives's State Street SPDR Bloomberg 1-3 Month T-Bill ETF position peaked at $322K in Q2 2021.
  • 506 funds tracked by Wall St. Rank held State Street SPDR Bloomberg 1-3 Month T-Bill ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.